A timeline of tau-mediated synaptotoxicity

Key Points

• The aim is to understand how oligomeric tau contributes to synaptic impairments in Alzheimer's disease.
• Analysis of tau-mediated synaptic deficits over time.
• Investigating the impact of oligomeric tau on synaptic health.
• Exploration of potential therapeutic strategies based on timeline insights.
• Oligomeric tau was linked to increasing synaptic impairments at specific timelines.
• Understanding tau's role may help in developing new treatments for synaptic loss.

Abstract